Form S-3ASR Disc Medicine, Inc.

Go back to Form S-3ASR Disc Medicine, Inc.

Disc Medicine (IRON) PT Raised to $50 at Raymond James

August 8, 2024 4:16 PM EDT

Raymond James analyst Danielle Brill raised the price target on Disc Medicine (NASDAQ: IRON) to $50.00 (from $43.00) while maintaining a Outperform rating.

The analyst comments "No changes to our Outperform rating following IRONs 2Q24 business and financial results, but we are raising... More